Resistance Training in Lung Cancer Patients on Chemotherapy
The purpose of this study is to examine the effectiveness of a resistance training program on reducing systemic inflammation and improving chemotherapy completion in lung cancer patients being treated with curative intent chemotherapy.
Ask AI to explain this studyKey things to know
This describes the study’s primary purpose.
The study team can explain what participation involves.
These are broad labels—not an eligibility decision.
Checked against the public recordLast updated Aug 20, 2015 · Source: ClinicalTrials.gov
Ask the study team to confirm whether enrollment is open.
Interventional
Locations may change over time.
Study sponsor
What this study is about
- Purpose
- Supportive Care
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- East Carolina University
- Interventions being studied
- Behavioral: Exercise
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.
- Histologically diagnosed with lung cancer
- Stage I, II, or III
- Eligible for chemotherapy with curative intent
- 21 years of age or older
- Approval to participate in study by treating oncologist or family physician
- Unstable cardiac disease
- Untreated bone or brain metastases
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Leo Jenkins Cancer CenterGreenville, North Carolina
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Aug 20, 2015. Always confirm current availability with the study team.